Form 4: TransMedics Group Director Basile Exercises Options and Sells Shares

Director Edward M. Basile exercised stock options and sold shares of TransMedics Group, Inc. on November 5, 2024, according to a Form 4 filing.

Summary

• On November 5, 2024, Edward M. Basile, a director of TransMedics Group, Inc., exercised stock options to acquire 6,750 shares of common stock at a price of $28.12 per share.
• Following the exercise of options, Basile sold a total of 6,750 shares in two separate transactions.
• The first sale involved 5,296 shares at a weighted average price of $83.35, with individual transactions ranging from $82.91 to $83.70.
• The second sale involved 1,454 shares at a weighted average price of $84.30, with individual transactions ranging from $84.00 to $84.70.
• After these transactions, Basile directly owns 732 shares of TransMedics Group, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. It doesn't indicate positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of insider transactions and provides insight into the actions of company directors. It is important to monitor such filings to understand management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates